Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis

Alpha-glucosidase inhibitors (AGIs) was reported to be associated with several rare adverse hepatic events, but with inconsistent results. We aimed to investigate the risk of hepatotoxicity associated with the use of AGIs in patients with type 2 diabetes mellitus (T2DM), and performed a systematic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Longhao, Chen, Qiyan, Li, Ling, Kwong, Joey S. W., Jia, Pengli, Zhao, Pujing, Wang, Wen, Zhou, Xu, Zhang, Mingming, Sun, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011653/
https://www.ncbi.nlm.nih.gov/pubmed/27596383
http://dx.doi.org/10.1038/srep32649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011653/
https://www.ncbi.nlm.nih.gov/pubmed/27596383
http://dx.doi.org/10.1038/srep32649

Ejemplares similares